{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T08:25:10Z","timestamp":1785054310232,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T00:00:00Z","timestamp":1587081600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jgar.2020.04.018","type":"journal-article","created":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T13:49:11Z","timestamp":1587736151000},"page":"553-561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Dynamics of in vitro development of azole resistance in Candida tropicalis"],"prefix":"10.1016","volume":"22","author":[{"given":"Saikat","family":"Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipti","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunaloke","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivaprakash M.","family":"Rudramurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anup K.","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2020.04.018_bib0005","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/S1473-3099(17)30316-X","article-title":"The global problem of antifungal resistance: prevalence, mechanisms, and management","volume":"17","author":"Perlin","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jgar.2020.04.018_bib0010","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1038\/emi.2017.74","article-title":"Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients","volume":"6","author":"Wu","year":"2017","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.jgar.2020.04.018_bib0015","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s00134-017-4743-y","article-title":"The risk and clinical outcome of candidemia depending on underlying malignancy","volume":"43","author":"Lortholary","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jgar.2020.04.018_bib0020","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00134-014-3603-2","article-title":"Incidence, characteristics and outcome of ICU-acquired candidemia in India","volume":"41","author":"Chakrabarti","year":"2015","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jgar.2020.04.018_bib0025","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3389\/fmicb.2017.00464","article-title":"Notable increasing trend in azole non-susceptible Candida tropicalis causing invasive candidiasis in China (August 2009 to July 2014): molecular epidemiology and clinical azole consumption","volume":"8","author":"Fan","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2020.04.018_bib0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/IDR.S124918","article-title":"Antifungal resistance: current trends and future strategies to combat","volume":"10","author":"Wiederhold","year":"2017","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jgar.2020.04.018_bib0035","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/s12879-017-2573-8","article-title":"Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species","volume":"17","author":"Ou","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jgar.2020.04.018_bib0040","first-page":"137","article-title":"Amino acid substitution in Cryptococcus neoformans lanosterol 14-\u03b1-demethylase involved in fluconazole resistance in clinical isolates","volume":"48","author":"Bosco-Borgeat","year":"2016","journal-title":"Rev Argent Microbiol"},{"key":"10.1016\/j.jgar.2020.04.018_bib0045","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1128\/AAC.00694-13","article-title":"Azole heteroresistance in Cryptococcus neoformans: emergence of resistant clones with chromosomal disomy in the mouse brain during fluconazole treatment","volume":"57","author":"Sionov","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.04.018_bib0050","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1128\/AAC.02287-12","article-title":"Azole resistance in Cryptococcus gattii from the Pacific Northwest: investigation of the role of ERG11","volume":"57","author":"Gast","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.04.018_bib0055","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02496-16","article-title":"ERG11 gene mutations and MDR1 upregulation confer pan-azole resistance in Candida tropicalis causing disseminated candidiasis in an acute lymphoblastic leukemia patient on posaconazole prophylaxis","volume":"61","author":"You","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.04.018_bib0060","first-page":"988","article-title":"Pan-azole-resistant Candida tropicalis carrying homozygous erg11 mutations at position K143R: a new emerging superbug?","volume":"72","author":"Xisto","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2020.04.018_bib0065","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12879-018-3082-0","article-title":"MDR1 overexpression combined with ERG11 mutations induce high-level fluconazole resistance in Candida tropicalis clinical isolates","volume":"18","author":"Jin","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jgar.2020.04.018_bib0070","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1007\/s10096-017-3034-4","article-title":"Cross-resistance between voriconazole and fluconazole for non-albicans Candida infection: a case-case-control study","volume":"36","author":"Wang","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2020.04.018_bib0075","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1128\/AAC.44.6.1578-1584.2000","article-title":"Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750","volume":"44","author":"Barchiesi","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.04.018_bib0080","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.3389\/fmicb.2016.02173","article-title":"Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species","volume":"7","author":"Whaley","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2020.04.018_bib0085","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1128\/AAC.02652-15","article-title":"Resistance mechanisms and clinical features of fluconazole-nonsusceptible Candida tropicalis isolates compared with fluconazole-less-susceptible isolates","volume":"60","author":"Choi","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.04.018_bib0090","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1128\/AAC.00477-13","article-title":"Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications","volume":"57","author":"Forastiero","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.04.018_bib0095","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/jac\/dks481","article-title":"Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China","volume":"68","author":"Jiang","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2020.04.018_bib0100","doi-asserted-by":"crossref","first-page":"4608","DOI":"10.1128\/AAC.49.11.4608-4615.2005","article-title":"Mechanisms of azole resistance in a clinical isolate of Candida tropicalis","volume":"49","author":"Vandeputte","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.04.018_bib0105","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.cmi.2018.11.007","article-title":"Molecular mechanisms of azole resistance in Candida tropicalis isolates causing invasive candidiasis in China","volume":"25","author":"Fan","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2020.04.018_bib0110","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1128\/AAC.00555-13","article-title":"Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals","volume":"57","author":"Eddouzi","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.04.018_bib0115","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1128\/AAC.37.9.1847","article-title":"Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients","volume":"37","author":"Wingard","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.04.018_bib0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/0255-0857.148834","article-title":"Effects of fluconazole treatment of mice infected with fluconazole-susceptible and -resistant Candida tropicalis on fungal cell surface hydrophobicity, adhesion and biofilm formation","volume":"33","author":"Souza","year":"2015","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.jgar.2020.04.018_bib0125","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/myc.12457","article-title":"Cross-resistance to fluconazole induced by exposure to the agricultural azole tetraconazole: an environmental resistance school?","volume":"59","author":"Rocha","year":"2016","journal-title":"Mycoses"},{"key":"10.1016\/j.jgar.2020.04.018_bib0130","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1567-1364.2009.00508.x","article-title":"Dynamics of in vitro acquisition of resistance by Candida parapsilosis to different azoles","volume":"9","author":"Pinto e Silva","year":"2009","journal-title":"FEMS Yeast Res"},{"key":"10.1016\/j.jgar.2020.04.018_bib0135","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1056\/NEJM199110313251803","article-title":"Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole","volume":"325","author":"Wingard","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgar.2020.04.018_bib0140","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/AAC.45.1.52-59.2001","article-title":"Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans","volume":"45","author":"Marr","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.04.018_bib0145","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.cmi.2014.11.009","article-title":"Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for the rapid identification of yeasts causing bloodstream infections","volume":"21","author":"Ghosh","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2020.04.018_bib0150","series-title":"PCR protocols, a guide to methods and applications","first-page":"315","article-title":"Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics","author":"White","year":"1990"},{"key":"10.1016\/j.jgar.2020.04.018_bib0155","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/mmy\/myx042","article-title":"Rapid detection of fluconazole resistance in Candida tropicalis by MALDI-TOF MS","volume":"56","author":"Paul","year":"2018","journal-title":"Med Mycol"},{"key":"10.1016\/j.jgar.2020.04.018_bib0160","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/jac\/dkz019","article-title":"Stable isotope labelling: an approach for MALDI-TOF MS-based rapid detection of fluconazole resistance in Candida tropicalis","volume":"74","author":"Paul","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2020.04.018_bib0165","volume":"vol. 28","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"key":"10.1016\/j.jgar.2020.04.018_bib0170","series-title":"M27-S4 reference method for broth dilution antifungal susceptibility testing of yeasts","author":"Clinical and Laboratory Standards Institute","year":"2012"},{"key":"10.1016\/j.jgar.2020.04.018_bib0175","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1038\/s41598-020-58744-7","article-title":"Selection and evaluation of appropriate reference genes for RT-qPCR based expression analysis in Candida tropicalis following azole treatment","volume":"10","author":"Paul","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jgar.2020.04.018_bib0180","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jgar.2020.04.018_bib0185","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/AAC.49.2.783-787.2005","article-title":"Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole","volume":"49","author":"Borst","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.04.018_bib0190","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1590\/S1517-83822009000400028","article-title":"Mutants with heteroresistance to amphotericin B and fluconazole in Candida","volume":"40","author":"Claudino","year":"2009","journal-title":"Braz J Microbiol"},{"key":"10.1016\/j.jgar.2020.04.018_bib0195","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1128\/AAC.41.8.1625","article-title":"Isolation of Candida species on media with and without added fluconazole reveals high variability in relative growth susceptibility phenotypes","volume":"41","author":"Schoofs","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.04.018_bib0200","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1128\/AAC.48.5.1788-1796.2004","article-title":"Mechanisms of azole resistance in petite mutants of Candida glabrata","volume":"48","author":"Brun","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.04.018_bib0205","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/jac\/49.3.515","article-title":"Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis","volume":"49","author":"Martinez","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2020.04.018_bib0210","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1128\/AAC.46.6.1695-1703.2002","article-title":"Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis","volume":"46","author":"Perea","year":"2002","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716520301107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716520301107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:54:21Z","timestamp":1761990861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716520301107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":42,"alternative-id":["S2213716520301107"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2020.04.018","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dynamics of in vitro development of azole resistance in Candida tropicalis","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2020.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}